By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Research and development of potential therapeutics for cancers, viruses and autoimmune disorders26K100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States170K100.00%